Cargando…
RespiCell(TM): An Innovative Dissolution Apparatus for Inhaled Products
To overcome some of the shortfalls of the types of dissolution testing currently used for pulmonary products, a new custom-built dissolution apparatus has been developed. For inhalation products, the main in vitro characterisation required by pharmacopoeias is the deposition of the active pharmaceut...
Autores principales: | Sonvico, Fabio, Chierici, Veronica, Varacca, Giada, Quarta, Eride, D’Angelo, Davide, Forbes, Ben, Buttini, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540329/ https://www.ncbi.nlm.nih.gov/pubmed/34683833 http://dx.doi.org/10.3390/pharmaceutics13101541 |
Ejemplares similares
-
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
por: D’Angelo, Davide, et al.
Publicado: (2023) -
Understanding the Importance of Capsules in Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2021) -
Recent Patents on Nasal Vaccines Containing Nanoadjuvants
por: Candela, Francesco, et al.
Publicado: (2022) -
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles
por: Quarta, Eride, et al.
Publicado: (2023) -
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
por: Quarta, Eride, et al.
Publicado: (2021)